U.S. Mortgage REITs Stock News

After a near doubling in the last year, Veeco Instruments now sits in a zone where recent gains and the latest valuation checks are no longer pointing to an obvious bargain, even though the share price has pulled back sharply in the past month. Veeco Instruments has returned 97.7% over the past year, which puts the recent selloff into context and raises the question of how much of the good news may already be reflected in the price. Future expectations for revenue growth and cash generation...

In the second quarter of 2026, QuantumScape Corporation reported a net loss of US$98.24 million and basic loss per share of US$0.16, both lower than the same period in 2025. Over the first half of 2026, QuantumScape cut its cumulative net loss to US$199.04 million and loss per share to US$0.32, highlighting a slower cash burn as it continues to fund solid-state battery development. Next, we will assess how this narrower quarterly net loss shapes QuantumScape’s investment narrative built...

Navios Maritime Partners has delivered very strong long term returns over the past five years, yet the current valuation checks still suggest the stock leans cheap rather than stretched. The stock has returned about 262.5% over 5 years. This puts a lot of focus on whether today’s price still offers a margin of safety. For a shipping partnership like Navios Maritime Partners, investor expectations around shipping rates and fleet utilisation can support the current valuation. At the same time,...

Talos Energy (TALO) is drawing attention ahead of its upcoming June 2026 quarter earnings report, with expectations for significant earnings growth and a positive Earnings ESP refocusing investor interest on the stock. See our latest analysis for Talos Energy. Talos Energy's share price has moved to $14.25 after a 1-day share price return of 4.24%, with the year to date share price return of 26.67% and 1-year total shareholder return of 61.20% pointing to building momentum despite some recent...

Renasant stock barely flinched after earnings, easing about 1% in Thursday trading, yet the results were anything but sleepy. The real story sits in profitability. Adjusted earnings per share for the quarter came in just under US$1, and net income held close to US$90 million, supported by a solid net interest margin and a tighter cost to income ratio than a year ago. Investors saw a quiet price move into these numbers and a much louder message in the income statement. The rest of the release...

Harrow recently presented three studies at the ASRS 2026 Annual Meeting highlighting interim clinical and real-world data for IHEEZO and BYOOVIZ in retinal care. The early IHEEZO data suggesting improved post-injection comfort without added antisepsis risk could meaningfully influence how ophthalmologists think about intravitreal procedures. We’ll now explore how encouraging interim IHEEZO pain and safety findings may influence Harrow’s investment narrative built around retina...

Four Corners Property Trust (FCPT) has combined an upsized credit facility with its largest acquisition to date, the Mission Pet Health portfolio, giving investors fresh information on both balance sheet structure and portfolio mix. See our latest analysis for Four Corners Property Trust. At a share price of $26.33, Four Corners Property Trust has recorded a 13.30% year to date share price return. The 1 year total shareholder return of 8.91% sits alongside multi year total shareholder returns...

Carter's, Inc. recently indicated that its Q2 2026 results would show top-line growth supported by stronger retail traffic, new customers, and brand collaborations such as Winnie the Pooh and Umbro, even as earnings per share are expected to fall compared with the prior year. This mix of revenue momentum and profit pressure highlights how Carter's is leaning on direct-to-consumer strength and pricing and productivity initiatives to offset tariffs, inflation, and cautious discretionary...

Global markets are wrestling with mixed inflation signals, shifting rate expectations and higher energy costs. That backdrop keeps investors focused on assets that can potentially benefit as digital infrastructure and new transaction systems evolve. The Top Cryptocurrency and Blockchain Stocks screener filters this wide universe into a more manageable starting list based on clear, transparent criteria. That helps you focus on businesses linked to crypto and blockchain themes without having to...

Murphy Oil previously announced it was expected to report higher year-over-year earnings and revenues for the June 2026 quarter, with the earnings release scheduled for August 5 and analyst models indicating a likely earnings beat based on an Earnings ESP of 0.25% and a Zacks Rank of 3. An interesting angle for investors is Murphy Oil’s consistent record of surpassing consensus EPS estimates in each of the last four quarters, which has fueled confidence in the company’s upcoming results...

In recent weeks, Buckley Capital Advisors highlighted Liquidia Corporation in its Q2 2026 investor letter, crediting the company as a major contributor to portfolio gains and expressing confidence in a favorable judicial ruling on Liquidia’s ability to sell Yutrepia for PH-ILD. This external investor commentary has sharpened attention on Liquidia’s legal outcomes and potential buyout interest, adding an additional layer of focus to the company’s existing product, earnings and pipeline...

Bicara Therapeutics recently appointed Jeremy Bender, Ph.D., MBA, former CEO of Day One Biopharmaceuticals, and ex-Genentech oncology leader Christy Oliger to its Board of Directors, while Kiran Mazumdar-Shaw retired from the board. The additions bring deep experience in oncology drug launches, large-scale portfolio management and major biotech M&A, potentially influencing how Bicara approaches late-stage development and commercialization decisions. Next, we’ll examine how adding experienced...

Globus Medical (GMED) stock drew renewed attention after its recent trading move, with the price closing at $81.42. Investors are now reassessing how its business profile and valuation stack up. See our latest analysis for Globus Medical. That latest move sits within a mixed picture. The 7 day share price return of 7.84% contrasts with a 30 day share price decline of 3% and a 90 day share price decline of 9.71%, while the 1 year total shareholder return of 52.33% points to stronger long run...

Hawkins (HWKN) is back in focus after reporting record first quarter revenue of US$315.7 million, a small year over year decline in earnings per share, and a 5% increase in its quarterly dividend. See our latest analysis for Hawkins. The earnings miss and softer EPS appear to be weighing on sentiment, with Hawkins’ share price down 17.2% over the past 90 days and its 1 year total shareholder return down 12.5%. However, 3 and 5 year total shareholder returns remain very strong multiples of the...

Essential Utilities’ board of directors recently declared a higher quarterly cash dividend of US$0.3606 per share, a 5.25% increase, payable on September 1, 2026, to shareholders of record as of August 11, 2026. This dividend increase highlights the company’s ongoing emphasis on returning cash to investors, reinforcing its long-running pattern of consistent payout growth within regulated utilities. With this latest dividend increase underscoring management’s confidence in sustained cash...

Simpson Manufacturing Co., Inc. recently declared a regular quarterly dividend of US$0.30 per share, payable on October 22, 2026 to stockholders of record as of October 1, 2026, and reported second-quarter results with net sales up 6.3% year on year alongside operating margin improvement to 25.2%. The combination of stronger-than-expected quarterly earnings, disciplined pricing, and cost control, plus an expanded US$200 million share repurchase authorization, highlights management’s focus on...

Consumer discretionary stocks sit right in the crosshairs of the latest US data, with slower 1.5% GDP growth in Q2, firm 3.3% core inflation, and solid 2.1% personal spending all pulling in different directions. That mix can reward companies with strong balance sheets and clear demand, while putting pressure on weaker business models. This article focuses on three consumer discretionary stocks from our screener that appear positively exposed to these trends. You will see how each one could...

After a strong three year run for Invesco stock, the valuation picture is not one sided. The intrinsic value estimate from the Excess Returns model points to meaningful upside relative to the share price, while the broader checks and market multiples suggest the stock is closer to fairly priced. Invesco has returned 96.7% over the past three years, which puts extra focus on whether the current price still offers an attractive entry level. The key support for the valuation is the market's...

Photronics stock has more than doubled over the past five years, yet its current valuation sends mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading at a premium, while market multiples suggest the stock still screens as undervalued. Photronics has returned 104.8% over five years, which puts more attention on whether the current price builds in much of that progress. Expectations for continued demand in its niche of semiconductor manufacturing...

Southwest Airlines (LUV) is back in focus after its second quarter 2026 report, with revenue of US$8,432 million and net income of US$233 million, alongside updated views on its growth and value profile. See our latest analysis for Southwest Airlines. At a share price of US$44.38, Southwest Airlines has seen its 1 month share price return fall 13.99% and its 7 day return decline 6.88%, even after a 90 day share price gain of 17.04% and a 1 year total shareholder return of 47.23%. This...

IMAX Corporation recently reported its second-quarter 2026 results, with revenue rising to US$102.84 million and net income to US$15.4 million, alongside continued execution of a long-running share repurchase program that has retired 26.36% of shares since 2017 for US$262.99 million. The combination of higher earnings per share from continuing operations and steady buybacks highlights how IMAX is pairing operational progress with ongoing capital returns to shareholders. Next, we’ll examine...

OPENLANE (OPLN) drew fresh attention after being highlighted alongside General Motors as an Auto Tires Trucks sector stock that has outperformed its group this year and currently carries a Zacks Rank of #2. See our latest analysis for OPENLANE. At a recent share price of US$40.44, OPENLANE has posted a strong 90 day share price return of 28.63% and a year to date share price return of 38.45%, while its 1 year total shareholder return of 64.06% and 3 year total shareholder return of about 2.6x...

Why Markel Group's Q2 2026 earnings matter for investors Markel Group (MKL) has just released Q2 2026 results, with net income and earnings per share significantly higher than a year ago, supported by stronger insurance underwriting and higher net investment income. The company also reported higher underwriting gross premium volume and operating income in its Markel Insurance segment, alongside continued share repurchases. This combination of operating and capital allocation decisions gives...

Ashland walked into this earnings season with a stock that had quietly climbed over the past quarter, yet the initial reaction today is a mild pullback of about 1%. That muted move masks a quarter that puts profit quality in the spotlight. Adjusted earnings per share reached US$1.02 on revenue of US$497m, while free cash flow came in at US$103m with conversion above 90%. For a specialty chemicals business in which cash generation and margin resilience matter more than headline growth, this...